Blogs about Biotechnology, Pharmaceutical and Healthcare
Read the latest opinions - blogs from pharmaceutical and life science industry experts.
Showing News Articles 1–25 of 34,000+
Download: Moleac- A Specialty Pharma in Neurology and Aging
Moleac brings together Asian and Western techniques by identifying medicine discovered in China and developing them into Western mainstream medicine. Moleac’s first product, Neuroaid (also [...]
China Pharmas See Foreign JVs, Other Ties As Routes To Global Markets
Increasingly, China's drug makers such as Zhejian Hisun Pharmaceutical and Simcere are entering joint ventures and other types of partnerships with multinational firms in a two-way dance that suits the growth interests of both parties.
India Health Ministry Said To Do Little To Deal With Foreign-Banned Drugs
Recent claims by India's health ministry that it was banning drugs also banned in nations with strong regulations, such as Australia, Canada, Japan, the EU, U.K. and U.S., amount to little more than appointing a committee, a parliamentary critic said...
By Shiv Gaglani What if the next time you step into your doctor’s office for an examination, she reaches into her white coat pocket and pulls out an iPhone instead of a stethoscope? That’s the idea behind The Smartphone Physical, a re-ima...
Japan Regenerative-Medicine Market Drives New Biotech Ventures
Japan's market for regenerative medicine, which includes players such as D. Western Therapeutics Institute, is helping to drive a surge in creation of biotechnology ventures, thanks in part to government financial support.
Turkey’s spending on drug reimbursement dropped last year as pressure was brought to bear on prices by the government, but manufacturers say the trend is unsustainable. The government says some of the TL 1.3 billion ($747 million) it saved was beca...
South Korea To Launch Global M&A Fund Based On Israel’s Yozma Model
South Korea’s public fund will help companies expand globally, because private investment is lacking.
Emerging Markets Regulatory Tracker: Australia, Brazil, China (Vol. 3 No. 31)
The Emerging Markets Regulatory Tracker is a periodic PharmAsia News feature that summarizes and links to important regulatory developments impacting the biopharma and medical device industries in the Asia Pacific region and other emerging markets.
SmithOnStocks Opines On Stocks: May 19th Edition
By Smith On Stocks: One Approach for Investing in Emerging Biotechnology Stocks I write on biotechnology and pharmaceutical companies of all sizes, but I have spent much of the last year focusing on small biotechnology companies ranging in size from as low as $50 million in market capitalization.to about $400 million. There is much less analyst and investor attention on these stocks, which can l...
Authorities Find Mail With Ricin In Spokane
Federal and state authorities searched a Spokane, Wash., apartment over the weekend as part of an investigation into ricin-laced letters that were addressed to the Spokane post office and a federal judge.
India's New Price Controls To Hit 652 Essential Drugs, Cutting Profits
India's new list of price-regulated essential drugs set to take effect in mid-June will cover 652 bulk drugs and their formulations, with GlaxoSmithKline and Sanofi Aventis to be the most adversely affected.
Report Says Australia's PBS Reached 20-Year Low In Adding New Drugs
Australia's Pharmaceutical Benefits Scheme has added the lowest number of new drugs to its subsidy list in 20 years, depriving patients of possible savings amounting to nearly $18 billion, according to a report.
Japan Medical Group To Prevent Repeats Of Tainted Novartis Diovan Trials
The Japanese Association of Medical Sciences has called a meeting to discuss ways to improve the nation's process of clinical trials in the wake of revelations Novartis studies of its Diovan (valsartan) blood-pressure drug may have been tainted.
As some states relax laws on pot possession, lawmakers are struggling to create rules for how police officers should identify motorists who are driving under the influence of marijuana.
Making mentally ill defendants ready for trial
KERRVILLE, Texas -- The judge ascended the bench. He looked down at cafeteria-style tables marked "Prosecuting Attorney" and "Defense Attorney." To his left, two men sat in a box marked "Jury." The witness stand was marked "Witness.""Sustained," proclaimed the judge, who …
Oramed Sweeps Past Worldwide Giants With The First Trial Of Orally Delivered Insulin
BySharon di Stefano:A hallmark disease of an overweight, desk bound nation, diabetes instigates a staggering economic burden on our healthcare system where total costs, including hospital inpatient care, doctor visits, medication, and reduced or lost productivity have been estimated at $245 billion in 2012, a 41% increase in the last five years. Further, diabetes costs the average sufferer $13,700...
Cardio vs. Weights: A Running Argument
A wife and husband differ about the best way to stay in shape. And the winner is…
Benjamin Graham's Rules For The Common Stock Component: Questcor Pharmaceuticals Inc.
ByJarrod W. Jacinth:The fifth chapter of The Intelligent Investors is titled "The Defense Investor and Common Stocks". In this chapter Benjamin Graham lays the conservative foundation for picking defensive stocks. Mr. Graham suggests four rules to guide the investor to fill their portfolio. There should be adequate though not excessive diversification. This might mean a minimum of ten diff...
By Spencer Osborne: With sales of anti-obesity drug Qsymia not progressing to the desired point, and cash burn at Vivus (VVUS) such that it was faced with either added debt, stock dilution through an offering, or finding a partner, Vivus seems to have chosen the former and came to terms on $220 million in 4.5% covertible notes due in 2020.This route should not have been unanticipated by anyone. Th...
China Biotech In Review: SciClone Pharma In-Licenses China Rights To Heart Failure Drug
By ChinaBio Today: Deals and Financings RuiYi Inc., a San Diego-Shanghai biotech startup, has signed an exclusive license and collaboration with Genor BioPharma of Shanghai to develop RuiYi's lead molecule in China. The drug candidate, RYI-008, is a novel anti-IL-6 monoclonal antibody with potential to treat autoimmune diseases and cancer.RuiYi also enlisted CMC Biologics to develop a cell lin...
Download: Optimizing Manufacturing Processes
At the 6th Annual BioPharma Convention 2013, we were honoured to invite Mr Ben Chen, Vice President & Chief Quality Officer of Shanghai Henlius Biotech [...]
Synthetic wheat breakthough in wheat breeding science offers greater yields
13/05/2013: NIAB NEWSUK wheat yields could be boosted by up to 30% with the introduction of a new wheat bred from a wild grass species.The National Institute of Agricultural Botany (NIAB) in Cambridge has recreated the original rare cross between a
Coffee consumption linked to reduced risk of autoimmune liver disease
Research presented today at Digestive Disease Week explores new discoveries in liver disease research, with findings about the impact of coffee on autoimmune disease and palliative care for cirrhotic patients. read more
For PTSD combat vets, ‘fear circuitry’ in the brain never rests
Chronic trauma can inflict lasting damage to brain regions associated with fear and anxiety. Previous imaging studies of people with post-traumatic stress disorder, or PTSD, have shown that these...
Frogs, salamanders suffering under erratic rainfall
By day, insects provide the white noise of the South, but the night belongs to the amphibians. In a typical year, the Southern air hangs heavy from the humidity and the sounds of wildlife. The...
